Studying biological mechanisms underlying neuropsychiatric disorders is highly challenging as many risk genes are associated with these disorders. This complexity requires research approaches to reliably dissect the cell biology of the risk genes involved. Here, we describe a combined cellomics–proteomics approach that allows (a) medium-throughput functional screening and unbiased selection of important risk genes, and (b) discovery of common functional pathways and interactome connections of selected risk genes. The overlay of pathway and proteome data from selected genes in a biological context can be used to formulate new testable hypothesis of both the genetics and the biology of the disorders
Neurological disorders are known to show similar phenotypic manifestations like anxiety, depression,...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Hundreds of genomic loci have been identified with the recent advances of schizophrenia in genome-wi...
An enigma in studies of neuropsychiatric disorders is how to translate polygenic risk into disease b...
With an increasing awareness of mental health issues and neurological disorders, “understanding the ...
The etiopathogenesis of many psychiatric illnesses remains unclear and a variety of these diseases c...
With an increasing awareness of mental health issues and neurological disorders, "understanding the ...
Although gene discovery in neuropsychiatric disorders, including autism spectrum disorder, intellect...
Proteomic studies have increased our understanding of the molecular pathways affected in psychiatric...
In order to accelerate the understanding of pathophysiological mechanisms and clinical biomarker dis...
Proteomics is the study of global gene expression of an organ, body system, fluid, or cellular compa...
Abstract Mental disorders (MDs), including schizophrenia (SCZ) and bipolar disorder (BD), have attra...
This dissertation examines significant risk loci identified through GWAS for neuropsychiatric illnes...
Approximately 25 % of the world population is affected by a mental disorder at some point in their l...
Psychiatric disorders such as Alzheimer's disease, schizophrenia and mood disorders are severe and d...
Neurological disorders are known to show similar phenotypic manifestations like anxiety, depression,...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Hundreds of genomic loci have been identified with the recent advances of schizophrenia in genome-wi...
An enigma in studies of neuropsychiatric disorders is how to translate polygenic risk into disease b...
With an increasing awareness of mental health issues and neurological disorders, “understanding the ...
The etiopathogenesis of many psychiatric illnesses remains unclear and a variety of these diseases c...
With an increasing awareness of mental health issues and neurological disorders, "understanding the ...
Although gene discovery in neuropsychiatric disorders, including autism spectrum disorder, intellect...
Proteomic studies have increased our understanding of the molecular pathways affected in psychiatric...
In order to accelerate the understanding of pathophysiological mechanisms and clinical biomarker dis...
Proteomics is the study of global gene expression of an organ, body system, fluid, or cellular compa...
Abstract Mental disorders (MDs), including schizophrenia (SCZ) and bipolar disorder (BD), have attra...
This dissertation examines significant risk loci identified through GWAS for neuropsychiatric illnes...
Approximately 25 % of the world population is affected by a mental disorder at some point in their l...
Psychiatric disorders such as Alzheimer's disease, schizophrenia and mood disorders are severe and d...
Neurological disorders are known to show similar phenotypic manifestations like anxiety, depression,...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Hundreds of genomic loci have been identified with the recent advances of schizophrenia in genome-wi...